Çпø¼Ò°³
±³À°°úÁ¤
Ãë¾÷½Ã½ºÅÛ
Ä¿¹Â´ÏƼ
Àλ縻
ÇпøµÑ·¯º¸±â
ÇпøÀ§Ä¡
°£È£Á¶¹«»ç
¿ä¾çº¸È£»ç
º´¿øÄÚµð³×ÀÌÅÍ
Ãë¾÷Áö¿ø°Ô½ÃÆÇ
°øÁö»çÇ×
Æ÷Åä°¶·¯¸®
Áú¹®´äº¯
>
Ãë¾÷ÁøÇÐ
>
Ãë¾÷¼¾ÅÍ
ÀÛ¼ºÀÚ
ºñ¹Ð¹øÈ£
±¸Àα¸Á÷
±¸ÀÎ
±¸Á÷
ȸ»ç¸í
Á¦¸ñ
------- ¿øº» ³»¿ë ---------
3 software, which was provided by the Cochrane Library
augmentin for bladder infection
When we inhibited PKA using a potent, cell permeable peptide, 31 the incidence of Ca 2 sparks was not significantly reduced in CPVT1p iPSC CMs Figure 5B
3 software, which was provided by the Cochrane Library
augmentin for bladder infection
When we inhibited PKA using a potent, cell permeable peptide, 31 the incidence of Ca 2 sparks was not significantly reduced in CPVT1p iPSC CMs Figure 5B